Reducing Airborne Microbes in the Surgical Operating Theater & Other Clinical Settings: A Study Utilizing the AiroCide System

The primary objective of the study is to determine the reduction of airborne microbial counts as a result of operating the AiroCide system in three clinical settings under control conditions. The three settings are Ear, Nose & Throat (ENT) Day Surgery, Surgical Operating Room (OR) and Surgical Instrument Sterile Preparation Room. 2) The second objective is to determine how/if the AiroCide system complimented existing heating, ventilation and air conditioning (HVAC) and other airflow or filtering systems in reducing airborne microbes. 3) The third objective is to examine statistical evidence related to the cost savings due to lessened risk factors of lower airborne microbial counts involving crosscontamination and nosocomial infections. Healthcare economics and patient comfort will be impacted if lower airborne microbial colonies result from the implementation of the AiroCide system.